Psychiatrist Dr Santhakumar dead

KOZHIKODE: Eminent psychiatrist and founder-director of the Institute of Mental Health and Neuro Sciences (IMHANS), Dr S Santhakumar, 87, passed away here on Thursday.

Santhakumar had been undergoing treatment for kidney ailments at a private hospital for the past two weeks.

He was a recipient of the Dr BC Roy National Award for excellence in the field of medicine in 2003.

After completing his MBBS from Stanley Medical College, Chennai, Santhakumar went on to pursue higher studies in USA, UK and Australia.

He had served as medical superintendent at government mental health centres at Kuthiravattam here and Oolampara in Thiruvananthapuram. He had also worked as head of the psychiatric department at the Kozhikode Government Medical College Hospital (KGMCH) before retiring as vice-principal of KGMCH.

He had written a number of books on psychiatry and had also served as member of the syndicate of the Calicut University.

Clinical psychologist Dr Philip John remembered Santhakumar as a legend with immense vision, relentless energy and the ability to make bold decisions. He pioneered the ‘medical’ discipline of psychiatry in Kerala, taking it away from the “story-telling psychiatry” of those days. His writings that integrated psychiatry and neurology changed the course of this speciality in this part of the world, he said.

Dr Santhakumar is survived by wife Dr M G Usha, daughter Dr Anjali Santhakumar and son Sanjay S Kumar. The funeral will be held at Mavoor Road crematorium at 10am on Friday.

  • Related Posts

    ‘Made in India’ Stents win major victory against Import Lobby

    New Delhi/ Ahmadabad: Gujarat’s Department of Health and Family welfare beat a hasty retreat on its biased order against domestic stent makers, thanks to immediate intervention of former Union Health…

    Is Gujarat’s Health Department Rebelling against PM Modi Government?

    Ahmedabad/ New Delhi: In a move that has stunned the medical industry and political circles alike; the Gujarat Health Department has introduced a differential pricing mechanism for stents under the…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

    Merger of Suven Pharma, Cohance Lifesciences to take effect from May 1

    Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion

    Dr Lal PathLabs Q4 profit rises 81% on volume growth, geographic expansion

    Lupin-led price cut slashes cost of key TB drug pretomanid by 25%

    Lupin-led price cut slashes cost of key TB drug pretomanid by 25%

    250% rally in one year! Multibagger pharma stock jumps despite stock market crash

    250% rally in one year! Multibagger pharma stock jumps despite stock market crash